Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.
|Articles|December 10, 2007
Latebreakers: Final DEA rule OKs multiple Schedule II Rxs
A final rule from the DEA allows doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II controlled substances.
Advertisement
Advertisement
Related to this article
In this episode, our hosts examine the expanding role of incretin therapies in children and adolescents with obesity and type 2 diabetes.
GLP-1 adherence requires integrated care teams, administrative technology, and proactive clinical support to tackle complex challenges.
Pharmacist Stephanie Young Moss explains menopause symptoms, hormone therapy guidance, and how pharmacists can expand menopause care access.
Research shows that cost-plus pricing can lower drug costs dramatically, depending on where in the supply chain the markup is applied.
Medicaid and Part D low-income subsidy enrollment narrowed some gaps, but much of the disparity occurred within the same plans.
In part 1 of our midterm election FAQ series, AJ Barbarito, Esq, breaks down ongoing legal developments for pharmacists and what a change in Congressional control could mean for the profession.
A modeling study projects that a structured lifestyle program for adults with prediabetes would be cost-effective and likely cost saving.
Advertisement
Advertisement
Trending on Drug Topics
1
FAQ: How the 2026 Midterms Could Reshape Pharmacy Policy
2
Addressing Medication Adherence in Cardiometabolic Health
3
Cost-Plus Pricing Reshapes Pharmacy, But Savings Are Not Guaranteed
4
How Pharmacists Can Join the Menopause Care Team
5